home / stock / elgxq / elgxq news
Furthering its mission to transform the treatment of aortic disorders, Endologix, Inc. (OTC: ELGXQ) (“Endologix” or the “Company”) today announced the first implant of its recently approved ALTO ® endograft outside of the United States, completed by Andrew Ho...
Endologix ( OTCPK:ELGXQ ) has received a CE Mark for the ALTO Abdominal Stent Graft System (ALTO). More news on: ENDOLOGIX INC, Healthcare stocks news, Read more ...
Transforming the treatment of aortic disorders, Endologix ® Inc. (OTC: ELGXQ) (“Endologix” or the “Company”), today announced that it has received a CE Mark for the ALTO™ Abdominal Stent Graft System (ALTO). “We are very excited to receive a...
News, Short Squeeze, Breakout and More Instantly...
Endologix Inc. Company Name:
ELGXQ Stock Symbol:
OTCMKTS Market:
Furthering its mission to transform the treatment of aortic disorders, Endologix, Inc. (OTC: ELGXQ) (“Endologix” or the “Company”) today announced the first implant of its recently approved ALTO ® endograft outside of the United States, completed by Andrew Ho...
Transforming the treatment of aortic disorders, Endologix ® Inc. (OTC: ELGXQ) (“Endologix” or the “Company”), today announced that it has received a CE Mark for the ALTO™ Abdominal Stent Graft System (ALTO). “We are very excited to receive a...